Stockreport

ARS Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF treated with a single dose—and ARS reported $72.2M U.S. net product revenue and $84.3M total revenue in 2025, its first full commercial year. Growth is constrained by [Read more]